{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:05:15Z","timestamp":1742645115959},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.7759\/cureus.33187","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T22:18:00Z","timestamp":1672525080000},"source":"Crossref","is-referenced-by-count":1,"title":["A Novel Tongue-Based Tumor With an RREB1-MRTFB Fusion: Variant Rhabdomyosarcoma or Aggressive Variant of Ectomesenchymal Chondromyxoid Tumor"],"prefix":"10.7759","author":[{"given":"Nuttavut","family":"Sumransub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Racila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paari","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conner","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Marette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Lassig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M","family":"Skubitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11550","article-title":"Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution","volume":"98","author":"Ferrari A","year":"2003","unstructured":"Ferrari A, Dileo P, Casanova M, et al.. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003, 98:571-80. 10.1002\/cncr.11550","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0183-RA","article-title":"An integrative morphologic and molecular approach for diagnosis and subclassification of rhabdomyosarcoma","volume":"146","author":"Fan R","year":"2022","unstructured":"Fan R, Parham DM, Wang LL. An integrative morphologic and molecular approach for diagnosis and subclassification of rhabdomyosarcoma. Arch Pathol Lab Med. 2022, 146:953-9. 10.5858\/arpa.2021-0183-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref3","article-title":"Soft Tissue and Bone Tumours: WHO Classification of Tumours, 5th Edition, Volume 3","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board. Soft Tissue and Bone Tumours: WHO Classification of Tumours, 5th Edition, Volume 3. IARC Publications, Lyon, France; 2020."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0051-2","article-title":"Rhabdomyosarcoma","volume":"5","author":"Skapek SX","year":"2019","unstructured":"Skapek SX, Ferrari A, Gupta AA, et al.. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019, 5:1. 10.1038\/s41572-018-0051-2","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2018.10.004","article-title":"Pleomorphic sarcomas: the state of the art","volume":"12","author":"Carvalho SD","year":"2019","unstructured":"Carvalho SD, Pissaloux D, Cromb\u00e9 A, Coindre JM, Le Loarer F. Pleomorphic sarcomas: the state of the art. Surg Pathol Clin. 2019, 12:63-105. 10.1016\/j.path.2018.10.004","journal-title":"Surg Pathol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0639","article-title":"Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors","volume":"4","author":"Shern JF","year":"2014","unstructured":"Shern JF, Chen L, Chmielecki J, et al.. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014, 4:216-31. 10.1158\/2159-8290.CD-13-0639","journal-title":"Cancer Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/path.4307","article-title":"Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma","volume":"232","author":"Szuhai K","year":"2014","unstructured":"Szuhai K, de Jong D, Leung WY, Fletcher CD, Hogendoorn PC. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. J Pathol. 2014, 232:300-7. 10.1002\/path.4307","journal-title":"J Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000538","article-title":"A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related Fusions in infantile cases","volume":"40","author":"Alaggio R","year":"2016","unstructured":"Alaggio R, Zhang L, Sung YS, et al.. A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related Fusions in infantile cases. Am J Surg Pathol. 2016, 40:224-35. 10.1097\/PAS.0000000000000538","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5591","article-title":"PAX3\/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification","volume":"30","author":"Missiaglia E","year":"2012","unstructured":"Missiaglia E, Williamson D, Chisholm J, et al.. PAX3\/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J Clin Oncol. 2012, 30:1670-7. 10.1200\/JCO.2011.38.5591","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.3814","article-title":"Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma","volume":"28","author":"Williamson D","year":"2010","unstructured":"Williamson D, Missiaglia E, de Reyni\u00e8s A, et al.. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol. 2010, 28:2151-8. 10.1200\/JCO.2009.26.3814","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001096","article-title":"Ectomesenchymal chondromyxoid tumor: a neoplasm characterized by recurrent RREB1-MKL2 fusions","volume":"42","author":"Dickson BC","year":"2018","unstructured":"Dickson BC, Antonescu CR, Argyris PP, et al.. Ectomesenchymal chondromyxoid tumor: a neoplasm characterized by recurrent RREB1-MKL2 fusions. Am J Surg Pathol. 2018, 42:1297-305. 10.1097\/PAS.0000000000001096","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.03.137","article-title":"PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group","volume":"20","author":"Sorensen PH","year":"2002","unstructured":"Sorensen PH, Lynch JC, Qualman SJ, et al.. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. J Clin Oncol. 2002, 20:2672-9. 10.1200\/JCO.2002.03.137","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22521","article-title":"RREB1-MKL2 fusion in biphenotypic \"oropharyngeal\" sarcoma: new entity or part of the spectrum of biphenotypic sinonasal sarcomas?","volume":"57","author":"Siegfried A","year":"2018","unstructured":"Siegfried A, Romary C, Escudi\u00e9 F, et al.. RREB1-MKL2 fusion in biphenotypic \"oropharyngeal\" sarcoma: new entity or part of the spectrum of biphenotypic sinonasal sarcomas?. Genes Chromosomes Cancer. 2018, 57:203-10. 10.1002\/gcc.22521","journal-title":"Genes Chromosomes Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.02.021","article-title":"Clinical features of ectomesenchymal chondromyxoid tumors: a systematic review of the literature","volume":"67","author":"Kato MG","year":"2017","unstructured":"Kato MG, Erkul E, Brewer KS, Harruff EE, Nguyen SA, Day TA. Clinical features of ectomesenchymal chondromyxoid tumors: a systematic review of the literature. Oral Oncol. 2017, 67:192-7. 10.1016\/j.oraloncology.2017.02.021","journal-title":"Oral Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199505000-00003","article-title":"Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity","volume":"19","author":"Smith BC","year":"1995","unstructured":"Smith BC, Ellis GL, Meis-Kindblom JM, Williams SB. Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol. 1995, 19:519-30. 10.1097\/00000478-199505000-00003","journal-title":"Am J Surg Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-020-01169-5","article-title":"Expanding awareness of the distribution and biologic potential of ectomesenchymal chondromyxoid tumor","volume":"15","author":"Bubola J","year":"2021","unstructured":"Bubola J, Hagen K, Blanas N, Weinreb I, Dickson BC, Truong T. Expanding awareness of the distribution and biologic potential of ectomesenchymal chondromyxoid tumor. Head Neck Pathol. 2021, 15:319-22. 10.1007\/s12105-020-01169-5","journal-title":"Head Neck Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/his.14080","article-title":"Mesenchymal tumours with RREB1-MRTFB fusion involving the mediastinum: extra-glossal ectomesenchymal chondromyxoid tumours?","volume":"76","author":"Makise N","year":"2020","unstructured":"Makise N, Mori T, Kobayashi H, et al.. Mesenchymal tumours with RREB1-MRTFB fusion involving the mediastinum: extra-glossal ectomesenchymal chondromyxoid tumours?. Histopathology. 2020, 76:1023-31. 10.1111\/his.14080","journal-title":"Histopathology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2021.12.042","article-title":"Ectomesenchymal chondromyxoid tumor with high-grade transformation","volume":"133","author":"Alshagroud DR","year":"2022","unstructured":"Alshagroud DR, Alghamdi DO, Dickson DB, Koutlas IG. Ectomesenchymal chondromyxoid tumor with high-grade transformation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022, 133:135-136. 10.1016\/j.oooo.2021.12.042","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128878-a-novel-tongue-based-tumor-with-an-rreb1-mrtfb-fusion-variant-rhabdomyosarcoma-or-aggressive-variant-of-ectomesenchymal-chondromyxoid-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:14Z","timestamp":1707508094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128878-a-novel-tongue-based-tumor-with-an-rreb1-mrtfb-fusion-variant-rhabdomyosarcoma-or-aggressive-variant-of-ectomesenchymal-chondromyxoid-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.33187","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,31]]}}}